Exosomal Communication Between the Tumor Microenvironment and Innate Immunity and Its Therapeutic Application

被引:12
作者
Kong, Hyunseok [1 ]
Kim, Sang Bum [2 ]
机构
[1] Sahmyook Univ, Dept Anim Resource Sci, Seoul 01795, South Korea
[2] Sahmyook Univ, Coll Pharm, 815 Hwarang Ro, Seoul 01795, South Korea
基金
新加坡国家研究基金会;
关键词
Exosomes; Tumor microenvironment; Cancer; Innate immunity; CELL-DERIVED EXOSOMES; NATURAL-KILLER-CELLS; DENDRITIC CELLS; EXTRACELLULAR VESICLES; SUPPRESSOR-CELLS; EXPRESSION; IMMUNOTHERAPY; INDUCTION; SECRETION; VACCINE;
D O I
10.4110/in.2022.22.e38
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Exosomes, which are well-known nanoscale extracellular vesicles, are multifunctional biomaterials derived from endosomes and perform various functions. The exosome is a critical material in cell- cell communication. In addition, it regulates the pathophysiological conditions of the tumor microenvironment in particular. In the tumor microenvironment, exosomes play a controversial role in supporting or killing cancer by conveying biomaterials derived from parent cells. Innate immunity is a crucial component of the host defense mechanism, as it prevents foreign substances, such as viruses and other microbes and tumorigenesis from invading the body. Early in the tumorigenesis process, the innate immunity explicitly recognizes the tumor via Ags and educates the adaptive immunity to eliminate it. Recent studies have revealed that exosomes regulate immunity in the tumor microenvironment. Tumor-derived exosomes regulate immunity against tumor progression and metastasis. Furthermore, tumor-derived exosomes regulate polarization, differentiation, proliferation, and activation of innate immune cells. Exosomes produced from innate immune cells can inhibit or support tumor progression and metastasis via immune cell activation and direct cancer inhibition. In this study, we investigated current knowledge regarding the communication between tumor-derived exosomes and innate immune cellderived exosomes (from macrophages, dendritic cells, NK cells, and neutrophils) in the tumor microenvironment. In addition, we discussed the potential development of exosomal immunotherapy using native or engineered exosomes against cancer.
引用
收藏
页数:24
相关论文
共 133 条
  • [1] Comparison of characteristics and tumor targeting properties of extracellular vesicles derived from primary NK cells or NK-cell lines stimulated with IL-15 or IL-12/15/18
    Aarsund, Miriam
    Segers, Filip M.
    Wu, Yunjie
    Inngjerdingen, Marit
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (09) : 2227 - 2238
  • [2] Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer
    Almatroodi, Saleh A.
    Almatroudi, Ahmad
    Khan, Amjad Ali
    Alhumaydhi, Fahad A.
    Alsahli, Mohammed A.
    Rahmani, Arshad Husain
    [J]. MOLECULES, 2020, 25 (14):
  • [3] Exosomes as potent cell-free peptide-based vaccine.: I.: Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells
    André, F
    Chaput, N
    Schartz, NEC
    Flament, C
    Aubert, N
    Bernard, J
    Lemonnier, F
    Raposo, G
    Escudier, B
    Hsu, DH
    Tursz, T
    Amigorena, S
    Angevin, E
    Zitvogel, L
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (04) : 2126 - 2136
  • [4] Tetraspanins in extracellular vesicle formation and function
    Andreu, Zoraida
    Yanez-Mo, Maria
    [J]. FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [5] Molecular profiles and immunomodulatory activities of glioblastoma-derived exosomes
    Azambuja, Juliana Hofstatter
    Ludwig, Nils
    Yerneni, Saigopalakrishna
    Rao, Aparna
    Braganhol, Elizandra
    Whiteside, Theresa L.
    [J]. NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
  • [6] Tumor-derived exosomes in the regulation of macrophage polarization
    Baig, Mirza S.
    Roy, Anjali
    Rajpoot, Sajjan
    Liu, Dongfang
    Savai, Rajkumar
    Banerjee, Sreeparna
    Kawada, Manabu
    Faisal, Syed M.
    Saluja, Rohit
    Saqib, Uzma
    Ohishi, Tomokazu
    Wary, Kishore K.
    [J]. INFLAMMATION RESEARCH, 2020, 69 (05) : 435 - 451
  • [7] Exosomes and Immune Response in Cancer: Friends or Foes?
    Barros, Francisco M.
    Carneiro, Fatima
    Machado, Jose C.
    Melo, Sonia A.
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [8] The Interplay of Exosomes and NK Cells in Cancer Biology
    Batista, Ines A.
    Quintas, Sofia T.
    Melo, Sonia A.
    [J]. CANCERS, 2021, 13 (03) : 1 - 24
  • [9] Designer exosomes as next-generation cancer immunotherapy
    Bell, Brandon M.
    Kirk, Isabel D.
    Hiltbrunner, Stefanie
    Gabrielsson, Susanne
    Bultema, Jarred J.
    [J]. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2016, 12 (01) : 163 - 169
  • [10] Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC
    Besse, Benjamin
    Charrier, Melinda
    Lapierre, Valerie
    Dansin, Eric
    Lantz, Olivier
    Planchard, David
    Le Chevalier, Thierry
    Livartoski, Alain
    Barlesik, Fabrice
    Laplanche, Agnes
    Ploix, Stephanie
    Vimond, Nadege
    Peguillet, Isabelle
    Thery, Clotilde
    Lacroix, Ludovic
    Zoernig, Inka
    Dhodapkar, Kavita
    Dhodapkar, Madhav
    Viaud, Sophie
    Soria, Jean-Charles
    Reiners, Katrin S.
    von Strandmann, Elke Pogge
    Vely, Frederic
    Rusakiewicz, Sylvie
    Eggermont, Alexander
    Pitt, Jonathan M.
    Zitvogel, Laurence
    Chaput, Nathalie
    [J]. ONCOIMMUNOLOGY, 2016, 5 (04):